Teens ages 16 and 17 in the United States are currently qualified for the Pfizer COVID-19 promoter shot, the US FDA and CDC have reported. The FDA uncovered its Emergency Use Authorization (EUA) development on December 9, noticing that qualified young people more likely than not got the essential antibody portions somewhere around a half […]
Continue Reading